Terms: = Ovarian cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Treatment
2627 results:
1. Phase 1a dose escalation study of ivonescimab (AK112/SMT112), an anti-PD-1/VEGF-A bispecific antibody, in patients with advanced solid tumors.
Frentzas S; Austria Mislang AR; Lemech C; Nagrial A; Underhill C; Wang W; Wang ZM; Li B; Xia Y; Coward JIG
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38642937
[TBL] [Abstract] [Full Text] [Related]
2. Common misconceptions and myths about ovarian cancer causation: a national cross-sectional study from palestine.
Elshami M; Jaber I; Alser M; Al-Slaibi I; Jabr H; Ubaiat S; Tuffaha A; Khader S; Khraishi R; Arafeh ZA; Al-Madhoun S; Alqattaa A; Yaseen A; El Hadi AA; Barhoush O; Hijazy M; Eleyan T; Alser A; Hziema AA; Shatat A; Almakhtoob F; Mohamad B; Farhat W; Abuamra Y; Mousa H; Adawi R; Musallam A; Albarqi SI; Abu-El-Noor N; Bottcher B
BMC Public Health; 2024 Apr; 24(1):1027. PubMed ID: 38609950
[TBL] [Abstract] [Full Text] [Related]
3. Population-based BRCA germline mutation screening in the Han Chinese identifies individuals at risk of BRCA mutation-related cancer: experience from a clinical diagnostic center from greater Shanghai area.
Wu Z; Zhang Q; Jin Y; Zhang X; Chen Y; Yang C; Tang X; Jiang H; Wang X; Zhou X; Yu F; Wang B; Guan M
BMC Cancer; 2024 Apr; 24(1):411. PubMed ID: 38566028
[TBL] [Abstract] [Full Text] [Related]
4. Subsequent management and outcomes after first-line PARP inhibitors progression in ovarian cancer patients.
Yuan H; Li N; Wu L; Yao H
J Ovarian Res; 2024 Apr; 17(1):70. PubMed ID: 38561819
[TBL] [Abstract] [Full Text] [Related]
5. PMFFNet: A hybrid network based on feature pyramid for ovarian tumor segmentation.
Li L; He L; Guo W; Ma J; Sun G; Ma H
PLoS One; 2024; 19(4):e0299360. PubMed ID: 38557660
[TBL] [Abstract] [Full Text] [Related]
6. The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial.
Giudice E; Huang TT; Nair JR; Zurcher G; McCoy A; Nousome D; Radke MR; Swisher EM; Lipkowitz S; Ibanez K; Donohue D; Malys T; Lee MJ; Redd B; Levy E; Rastogi S; Sato N; Trepel JB; Lee JM
Nat Commun; 2024 Mar; 15(1):2805. PubMed ID: 38555285
[TBL] [Abstract] [Full Text] [Related]
7. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
[No Abstract] [Full Text] [Related]
8. A Survival Analysis of Patients with Recurrent Epithelial ovarian cancer Based on Relapse Type: A Multi-Institutional Retrospective Study in Armenia.
Harutyunyan L; Manvelyan E; Karapetyan N; Bardakhchyan S; Jilavyan A; Tamamyan G; Avagyan A; Safaryan L; Zohrabyan D; Movsisyan N; Avinyan A; Galoyan A; Sargsyan M; Harutyunyan M; Nersoyan H; Stepanyan A; Galstyan A; Danielyan S; Muradyan A; Jilavyan G
Curr Oncol; 2024 Mar; 31(3):1323-1334. PubMed ID: 38534933
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological features and surgical procedures of adnexal masses with abdominal pain in pediatric and adolescent patients.
Liu Q; Li Z; Zhou H; Cao D; Yang J; Shen K; Lang J
Orphanet J Rare Dis; 2024 Mar; 19(1):132. PubMed ID: 38515195
[TBL] [Abstract] [Full Text] [Related]
10. Predictive value of the Adult Comorbidity Evaluation 27 on adverse surgical outcomes and survival in elderly with advanced epithelial ovarian cancer undergoing cytoreductive surgery.
Zhao M; Gao Y; Yang J; He H; Su M; Wan S; Feng X; Wang H; Cai H
Eur J Med Res; 2024 Mar; 29(1):179. PubMed ID: 38494480
[TBL] [Abstract] [Full Text] [Related]
11. A survey of carboplatin desensitization therapy in Japan: A multicenter retrospective study.
Komatsu H; Matsumoto K; Morita M; Nagasawa T; Nishio H; Suzuki J; Nishio S; Kobara H; Yunokawa M; Ariyoshi K; Hirayama T; Tokunaga H; Ukita M; Yoriki K; Mori-Uchino M; Furusawa A; Togami S; Nakamura H; Ishikawa M; Satoh T
Cancer Med; 2024 Mar; 13(5):e6968. PubMed ID: 38491829
[TBL] [Abstract] [Full Text] [Related]
12. Effect of angiogenesis inhibitors on wound healing in patients with ovarian cancer: A meta-analysis.
Li X; Zeng D; Shi J
Int Wound J; 2024 Mar; 21(3):e14737. PubMed ID: 38468423
[TBL] [Abstract] [Full Text] [Related]
13. A Relative Bioavailability, Bioequivalence, and Food Effect Study of Niraparib Tablets in Patients with Advanced Solid Tumors.
Falchook G; Patnaik A; Richardson DL; Harvey RD; Sharma MR; Hafez N; Hamilton E; Piha-Paul SA; Barve M; Wise-Draper T; Patel MR; Dowlati A; Pascuzzo J; Tang SC; Faltermeier C; Malinowska IA; Shtessel L; Striha A; Potocka E
Clin Ther; 2024 Mar; 46(3):228-238. PubMed ID: 38423866
[TBL] [Abstract] [Full Text] [Related]
14. Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International cancer Benchmarking Partnership (ICBP) population-based study.
McPhail S; Barclay ME; Johnson SA; Swann R; Alvi R; Barisic A; Bucher O; Creighton N; Denny CA; Dewar RA; Donnelly DW; Dowden JJ; Downie L; Finn N; Gavin AT; Habbous S; Huws DW; May L; McClure CA; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Shack L; Tian X; Thomas RJS; Thomson CS; Wang H; Woods RR; You H; Lyratzopoulos G;
Lancet Oncol; 2024 Mar; 25(3):338-351. PubMed ID: 38423048
[TBL] [Abstract] [Full Text] [Related]
15. Evaluating the Prognostic Factors and Survival Rates of Endometrial cancer Patients in a Tertiary Referral Hospital in Northeast Thailand.
Wannasin R; Thinkhamrop K; Kelly M; Likitdee N
Asian Pac J Cancer Prev; 2024 Feb; 25(2):671-679. PubMed ID: 38415555
[TBL] [Abstract] [Full Text] [Related]
16. The risk factors for premalignant and malignant endometrial polyps in premenopausal and postmenopausal women and trends over the past decade: A retrospective study in a single center, South Korea.
Jang S; Hwang SO
Eur J Obstet Gynecol Reprod Biol; 2024 Apr; 295():118-123. PubMed ID: 38354603
[TBL] [Abstract] [Full Text] [Related]
17. Longitudinal Outcomes of Malignant Ureteral Obstruction Secondary to ovarian cancer: Predictors of Resolution and the Role of Surgical Management.
Faidley KN; Botkin HE; Loeffler BT; Mott SL; Hansen SC; Hill EK; Erickson BA
Urology; 2024 Apr; 186():101-106. PubMed ID: 38350551
[TBL] [Abstract] [Full Text] [Related]
18. Cost-Effectiveness Analysis of HRD Testing for Previously Treated Patients with Advanced ovarian cancer in Italy.
Rognoni C; Lorusso D; Costa F; Armeni P
Adv Ther; 2024 Apr; 41(4):1385-1400. PubMed ID: 38329713
[TBL] [Abstract] [Full Text] [Related]
19. Targeting BRCA and PALB2 in Pancreatic cancer.
Anbil S; Reiss KA
Curr Treat Options Oncol; 2024 Mar; 25(3):346-363. PubMed ID: 38311708
[TBL] [Abstract] [Full Text] [Related]
20. Serum anti-Müllerian hormone is lower in patients with multiple radioiodine dose for treatment of pediatric thyroid cancer.
Barreto MCA; Treistman N; Cavalcante LBCP; Bulzico D; de Andrade FA; Corbo R; Alves Junior PAG; Vaisman F
Eur Thyroid J; 2024 Apr; 13(2):. PubMed ID: 38290210
[TBL] [Abstract] [Full Text] [Related]
[Next]
